Viatris Inc.

Iconic Profile

Viatris Inc (VTRS) is a global healthcare company formed through the merger of Mylan and Upjohn, a division of Pfizer, focusing on providing access to medicines across a wide range of therapeutic areas. With a market capitalization of $20.6 billion, Viatris operates in the pharmaceuticals sector, offering a diverse portfolio that includes generic and branded medications, over-the-counter products, and complex generics. The company is positioned as a significant player in the pharmaceutical industry, emphasizing sustainability, affordability, and patient-centric solutions. Viatris matters in the healthcare landscape due to its commitment to improving patient access to essential medicines globally, while also addressing challenges such as rising healthcare costs and the need for innovative treatments. Its extensive global reach and operational capabilities enable it to respond effectively to market demands and contribute to public health outcomes.